Mobile Health Technology for Weight Loss in Bone Marrow Transplant Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the effectiveness of a mobile health app, W8L2G, designed to aid weight loss in patients who have undergone a bone marrow transplant (HSCT). The app addresses addictive eating habits and boosts motivation through coaching over four months. It is especially suited for those struggling with obesity after their transplant. Eligible participants include teens and young adults, aged 13 to 30, who are at least 100 days post-transplant and can read English. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve post-transplant care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the W8L2G mobile health app is safe for weight loss in bone marrow transplant patients?
Research has shown that mobile health (mHealth) apps, such as the W8L2G app, are generally safe for users. These apps have been used in studies to help people manage their weight and encourage healthy habits. For instance, one study on a similar weight management app found that users liked it, and no serious side effects were reported.
Weight loss apps typically focus on tracking habits and offering guidance. This method is considered safe because it involves changing behaviors rather than using medications or undergoing medical procedures. The W8L2G app follows this approach by providing support and motivation for making healthier choices.
While this pilot study is still examining the app's effectiveness, previous research has shown promise in using apps for weight management. No negative effects have been reported in the sources, suggesting the app is likely well-tolerated. However, since this is a new area of study, participants should report any problems they experience while using the app.12345Why are researchers excited about this trial?
Unlike traditional weight loss methods for bone marrow transplant patients, which often involve diet and exercise programs or medications, the W8L2G mobile health app offers a unique approach through technology. This app uses an addiction model-based intervention combined with personalized coaching over a mobile platform, making it highly accessible and convenient. Researchers are excited because this method not only provides continuous support but also harnesses the power of digital health to potentially offer more engaging and tailored weight loss strategies.
What evidence suggests that the W8L2G mobile health app is effective for weight loss in bone marrow transplant patients?
Research shows that mobile health apps can help people lose weight. Studies have found these apps to be a cost-effective and accessible alternative to traditional weight loss programs. In this trial, participants will use the W8L2G mobile health app, which shows promise for managing weight, particularly for groups like bone marrow transplant patients. The app is tested using an addiction model that focuses on changing behaviors, making it potentially helpful for those with addictive eating habits. Overall, mobile health technology appears promising for supporting weight loss in challenging medical situations.15678
Who Is on the Research Team?
Theodore B Moore, MD
Principal Investigator
UCLA Health
Are You a Good Fit for This Trial?
This trial is for English-reading individuals aged 13 to 30 who are considered obese (BMI ≥85th percentile) and have had any type of hematopoietic stem cell transplant at least 100 days before starting the study.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive an addiction model based mobile health (mHealth) weight loss intervention with coaching
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- W8L2G mobile health (mHealth) app
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor